IFNAR1 and infection: Yet, in cancer cells receiving ACM, the addition of IFNAR blocking antibody did not alleviate resistance to VSVΔ51 infection, suggesting an IFNAR-independent mechanism of OV resistance (Supplementary Figure 4A).